The ocular oncology laboratory is dedicated to research leading directly to better treatments for ocular tumors. The focus is on combined modality focal therapies. Experimental models are utilized to investigate tumor responses to periocular chemotherapy, external beam radiotherapy, and hyperthermia. The lab actively translates new findings to the clinic.
Directed by Dr. J. William Harbour, the lab focuses on the identification of genetic, epigenetic and genomic abnormalities that lead to poor patient outcome in uveal melanoma, retinoblastoma and other eye cancers, with the goal of developing more accurate prognostic biomarkers and targeted molecular therapies that will lead to improved survival.
Read more about the lab’s current research projects and highlights.
Meet the ocular oncology laboratory’s team of visionary scientists.
The ocular oncology group is comprised of a dedicated team of researchers whose goal is to improve patient survival and discover new cancer breakthroughs.
J. William Harbour, M.D.
Director of Ocular Oncology
Mark J. Daily Chair in Ophthalmology
Vice Chairman for Translational Research
Read more about Dr. Harbour
Biomedical Research Building